Research Oral Abstract Session - Addressing Drug Related Harms
Tracks
Track 1
Wednesday, October 13, 2021 |
2:25 PM - 3:55 PM |
Speaker
Dr Annie Madden
Project Lead
International Network Of People Who Use Drugs (inpud)
Professor Suzanne Nielsen
Professor
Monash University
Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia
3:25 PM - 3:30 PMBiography
Suzanne Nielsen (BPharmSc[Hons] PhD MPS) is an Associate Professor, and Deputy Director of the Monash Addiction Research Centre in Melbourne. Her current research focuses on expanding evidence-based treatment for opioid use disorder, monitoring for new psychoactive substances and and community overdose prevention.
Professor Michael Farrell
Director
National Drug & Alcohol Research Centre, UNSW Sydney
An open-label, multicentre, single-arm trial of monthly injections of extended release buprenorphine in people with opioid use disorder: The COLAB study
2:30 PM - 2:45 PMBiography
Professor Michael Farrell is the Director of NDARC since 2011. Before that he was Professor of Addiction Psychiatry at Kings College London. He has been a member of the WHO Expert Committee on Drug and Alcohol Dependence since 1995.
Conjoint Prof Adrian Dunlop
Director, Senior Staff Specialist
Drug & Alcohol Clinical Services, HNE Health
The UNLOC-T trial: implementing depot buprenorphine in NSW correctional facilities
2:45 PM - 3:00 PMBiography
Adrian Dunlop MBBS GdipEpiBiostat PhD FAChAM is Director and Senior Staff Specialist of Drug & Alcohol Clinical Services, Hunter New England Health Clinical Services, Conjoint Professor, Faculty of Health, University of Newcastle, Honorary Medical Officer, Justice Health and Forensic Mental Health Network, and DASAS consultant, St Vincent’s LHN.
Professor Louisa Degenhardt
Scientia Professor
NDARC
Ms Elin Holmén
Psychiatric nurse/PhD Student
Stockholm Centre For Dependency Disorders/karolinska Institute
High levels of uptake and use of naloxone among participants in a Take-Home-Naloxone program in Stockholm, Sweden
3:20 PM - 3:25 PMBiography
I am a nurse based at the Stockholm needle exchange and I was recently accepted as a Doctoral student. The title of my doctoral project is “Interventions for reducing mortality and morbidity among people who inject drugs – effects and experiences of a needle exchange program and naloxone distribution”.
Ms Chrianna Bharat
Phd Candidate
NDARC
The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: 15-year retrospective cohort study
3:25 PM - 3:30 PMBiography
Chrianna is an applied biostatistician who has worked at the National Drug & Alcohol Research Centre since 2016. Now in the third year of her PhD, Chrianna's doctoral research investigates the potential for linked data and predictive modelling to improve the prevention and treatment of opioid dependence.
Dr Paul Dietze
: Co_director, Disease Elimination Program
Burnet Insitute
Does take-home naloxone program participation result in the use of naloxone at witnessed overdoses: findings from a cohort study of the implementation of the UNODC-WHO Stop Overdose Safely Initiative in Kazakhstan, Kyrgyzstan, Tajikistan and Ukraine.
3:30 PM - 3:35 PMBiography
Paul Dietze is one of Australia's leading alcohol and other drug researchers, with a track record in research and intervention around opioid overdose in particular.
Dr Anna Conway
Research Associate
Kirby Institute, UNSW
“We’ve had a circuit breaker for an old dogma of more than 20 years”: changes to opioid agonist treatment services during COVID-19, the CHOICE Study
3:35 PM - 3:40 PMBiography
Anna Conway is a PhD candidate in the Kirby Institute and the Centre for Social Research in Health, investigating health service use and health outcomes in people who use opioids.
Dr Dragos Vlad
Medical Resident
Research Centre, Centre Hospitalier De L’université De Montréal
Determinants of long-term retention in opioid agonist therapy among people who inject drugs in Montreal, Canada
3:40 PM - 3:45 PMBiography
Dragos Vlad is a student at Montreal School of Public Health, where he is currently completing a Master’s degree in Epidemiology. His work alongside Dre Julie Bruneau’s team focuses on identifying individual and programmatic factors associated with retention in opioid agonist therapy for people with an opioid use disorder.
Dr Kennedy Kipkoech
Senior Research Associate
University of Bristol
Trends and factors associated with drug use in South Africa: findings from multiple national population-based household surveys
3:45 PM - 3:50 PMBiography
Mr Kipkoech is a Statistician/Modeler and currently a PhD Student specializing in Infectious Disease Modeling. He has 10 years’ experience working in research and policy at health-research and government institutions. His research interest focuses on the use of epidemiological/statistical/modeling approaches to understand transmission dynamics and control of infectious diseases.
Chair
Mary Harrod
CEO
NUAA
Daniel O'Keefe
Senior Research Officer
Burnet Institute
Speaker - will not appear in Portal
Chrianna Bharat
Phd Candidate
NDARC
Anna Conway
Research Associate
Kirby Institute, UNSW
Louisa Degenhardt
Scientia Professor
NDARC
Paul Dietze
: Co_director, Disease Elimination Program
Burnet Insitute
Adrian Dunlop
Director, Senior Staff Specialist
Drug & Alcohol Clinical Services, HNE Health
Michael Farrell
Director
National Drug & Alcohol Research Centre, UNSW Sydney
Elin Holmén
Psychiatric nurse/PhD Student
Stockholm Centre For Dependency Disorders/karolinska Institute
Kennedy Kipkoech
Senior Research Associate
University of Bristol
Dragos Vlad
Medical Resident
Research Centre, Centre Hospitalier De L’université De Montréal
